Company Overview and News
Recently appointed chief operating officer (COO) at GoAir, Jyri Strandman, has quit the airline, adding to the spate of resignations at the Wadia Group promoted budget carrier. Strandman’s exit will be the seventh exit of senior level executives in the last three months.
People taller than 6 feet can no longer fit in airline seats, a recent lawsuit alleges
Chicago, IL – September 11, 2018 – Zacks Equity Research Apple (AAPL - Free Report) as the Bull of the Day, Alaska Air Group (ALK - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Ribbon Communications, Inc. (RBBN - Free Report) , Avid Technology, Inc. (AVID - Free Report) and Camtek Ltd. (CAMT - Free Report) .
CAMT RBBN BRK.A VA AVID AAPL CSL ALK
Shares of Alaska Air Group (ALK - Free Report) , which owns Alaska Airlines and Horizon Air, have slipped roughly 8% since the start of the year due to rising fuel costs. ALK stock has jumped over the last three months, but the firm’s outlook doesn’t seem very promising.
SWRAY SWRBY SKYW ALK AFLYY HOME VA AFRAF GM SWRBF SWRAF
The Spice Girls' debut album, released in 1996, went on to sell more than 20 million copies.
Welcome to ViaSat's Fiscal Year First Quarter Earnings Conference Call. Your host for today's call is Mark Dankberg, Chairman and CEO. You may proceed, Mr. Dankberg.
VA VSAT MS
It’s the end of an era for Virgin America, which is the best reason to celebrate the good times.
2018-07-26 zacks - 1
Alaska Air Group, Inc. (ALK - Free Report) ) reported second-quarter 2018 earnings per share (excluding 10 cents from non-recurring items) of $1.66 per share, surpassing the Zacks Consensus Estimate of $1.63. Earnings declined on a year-over-year basis mainly due to high fuel costs.
2018-07-13 seekingalpha - 2
"The greatest shortcoming of the human race is our inability to understand the exponential function." -Albert Bartlett
LBRDB LSXMB BATRK FWONB AAL LSXMA BATRR LBRDK FWONA VA AN CHTR FWONK BATRB LSXMK LBRDA DAL BATRA TIVO
The U.S. Global Jets ETF (NYSEARCA:JETS) is a collection of 33 companies that participate in the global airline industry. A significant number are airline stocks while the remainder are aircraft manufacturers or play some part in airline travel.
VA AAL ALK LUV
Good morning and welcome to the Sabre First Quarter 2018 Earnings Conference Call. Please note that today's call is being recorded and is also being broadcast live over the Internet on the Sabre corporate website. This broadcast is the property of Sabre. Any redistribution, retransmission or rebroadcast of this call in any form without the express written consent of the company is strictly prohibited.
FGETF 0753 VA AICAF AFRAF ACDVF AIRC AIRYY FGHRY SABR AFLYY AC
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to VA / Virgin America Inc. on message board site Silicon Investor.
as of ET